NHS Seeks More Black Blood Donors

Demand for a specialist blood type used to treat sickle cell disease has surged across the past decade, pushing the NHS to call for more Black donors to come forward.

Reports indicate requests for haemoglobin S-negative blood, commonly used in transfusions for people with sickle cell anaemia, rose from 82,181 units in 2015 to more than 191,000 units last year. That amounts to a 132% increase in 10 years, a jump that underscores growing pressure on the blood supply for a condition that already requires closely matched donations.

The appeal reflects a hard medical reality: patients with sickle cell disease often need blood that closely matches their own, and donors of Black heritage can play a crucial role in meeting that need. As demand climbs, shortages can make routine care harder to manage and leave health services scrambling to secure the right blood at the right time.

The NHS appeal signals more than a recruitment drive — it points to a widening gap between rising sickle cell treatment needs and the specialist blood supply required to meet them.

The rise also points to a broader shift in healthcare demand. Sickle cell remains a serious and often under-recognized condition, and transfusion support forms a key part of treatment for many patients. When requests for a specific blood type more than double in a decade, the strain does not stay inside hospital walls; it reaches donor services, community outreach efforts, and long-term planning across the health system.

What happens next will depend on whether the NHS can turn this warning into sustained donor recruitment, especially among communities most likely to provide the best matches. If that effort succeeds, patients with sickle cell disease could see more reliable access to care. If it falls short, pressure on an already stretched supply will only intensify.